CHAPTER 1 INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENT
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1.KEY FINDINGS OF THE STUDY
2.2.CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTERS FIVE FORCES ANALYSIS

3.3.1.Bargaining power of buyers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of substitutes
3.3.4.Threat of new entrants
3.3.5.Competitive rivalry

3.4.TOP PLAYERS POSITIONING, 2016
3.5.MARKET DYNAMICS

3.5.1.Drivers

3.5.1.1.Increase in geriatric population
3.5.1.2.Increase in prevalence of chronic diseases
3.5.1.3.Increase in trauma cases and traffic accidents
3.5.1.4.Wide advantages of IV therapy and vein access devices

3.5.2.Restraint

3.5.2.1.Risk of allergic reaction and requirement of skilled professionals
3.5.2.2.Stringent government regulations

3.5.3.Opportunity

3.5.3.1.Lucrative opportunities from emerging economies

CHAPTER 4 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.IMPLANTABLE PORT

4.2.1.Key market trends
4.2.2.Key growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Single Lumen Implantable Port

4.2.4.1.Market size and forecast

4.2.5.Double Lumen Implantable Port

4.2.5.1.Market size and forecast

4.3.INTRAVENOUS CATHETER

4.3.1.Key market trends
4.3.2.Key growth factors and opportunities
4.3.3.Market size and forecast
4.3.4.Peripheral Intravenous Catheter

4.3.4.1.Market size and forecast

4.3.5.Central Intravenous Catheter

4.3.5.1.Market size and forecast

4.3.6.Peripherally Inserted Central Catheter

4.3.6.1.Market size and forecast

4.4.HYPODERMIC NEEDLES

4.4.1.Key market trends
4.4.2.Key growth factors and opportunities
4.4.3.Market size and forecast

4.5.INFUSION PUMPS

4.5.1.Key market trends
4.5.2.Key growth factors and opportunities
4.5.3.Market size and forecast

4.6.OTHER PRODUCTS

4.6.1.Key market trends
4.6.2.Key growth factors and opportunities
4.6.3.Market size and forecast

CHAPTER 5 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY MEDICAL APPLICATION

5.1.OVERVIEW

5.1.1.Market size and forecast

5.2.VOLUME EXPANDERS

5.2.1.Market size and forecast

5.3.MEDICATION ADMINISTRATION

5.3.1.Market size and forecast

5.4.BLOOD BASED PRODUCTS

5.4.1.Market size and forecast

5.5.NUTRITION AND BUFFER SOLUTION

5.5.1.Market size and forecast

CHAPTER 6 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER

6.1.OVERVIEW

6.1.1.Market size and forecast

6.2.HOSPITALS

6.2.1.Market size and forecast

6.3.AMBULATORY SURGICAL CENTERS

6.3.1.Market size and forecast

6.4.CLINICS

6.4.1.Market size and forecast

CHAPTER 7 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY GEOGRAPHY

7.1.OVERVIEW

7.1.1.Market size and forecast

7.2.NORTH AMERICA

7.2.1.Key market trends
7.2.2.Key growth factors and opportunities
7.2.3.Market size and forecast
7.2.4.U.S. market size and forecast
7.2.5.Canada market size and forecast
7.2.6.Mexico market size and forecast

7.3.EUROPE

7.3.1.Key market trends
7.3.2.Key growth factors and opportunities
7.3.3.Market size and forecast
7.3.4.Germany market size and forecast
7.3.5.France market size and forecast
7.3.6.UK market size and forecast
7.3.7.Italy market size and forecast
7.3.8.Spain market size and forecast
7.3.9.Rest of Europe market size and forecast

7.4.ASIA-PACIFIC

7.4.1.Key market trends
7.4.2.Key growth factors and opportunities
7.4.3.Market size and forecast
7.4.4.Japan market size and forecast
7.4.5.China market size and forecast
7.4.6.India market size and forecast
7.4.7.Rest of Asia-Pacific market size and forecast

7.5.LAMEA

7.5.1.Key market trends
7.5.2.Key growth factors and opportunities
7.5.3.Market size and forecast
7.5.4.Latin America market size and forecast
7.5.5.Middle East market size and forecast
7.5.6.Africa market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1.BECTON, DICKINSON AND COMPANY

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4. Key Strategic Moves & Developments

8.2. B.BRAUN MELSUNGEN AG

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4.Key Strategic Moves & Developments

8.3.TERUMO MEDICAL CORPORATION

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4.Key Strategic Moves & Developments

8.4.TELEFLEX MEDICAL INC.

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4.Key Strategic Moves & Developments

8.5.MEDTRONIC INC.

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4. Key Strategic Moves & Developments

8.6.SMITH & NEPHEW PLC.

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4.Key Strategic Moves & Developments

8.7.ANGIODYNAMICS, INC.

8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4.Key Strategic Moves & Developments

8.8.PFIZER INC.

8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4. Key Strategic Moves & Developments

8.9.INSULET CORPORATION

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4. Key Strategic Moves & Developments

8.10.FRESENIUS SE & CO. KGAA

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4. Key Strategic Moves & Developments